Impact of Smoking on Lung Cancer Treatment Effectiveness: A Review

References

• U.S. Department of Health and Human Services . The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA, USA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2014). http://ash.org/wp-content/uploads/2014/01/full-report.pdf.
   Google Scholar
• Hecht SS . More than 500 trillion molecules of strong carcinogens per cigarette: use in product labeling?Tobacco Control20, 387 (2011).
   PubMed Web of Science ®Google Scholar
• Zon RT , GossE, VogelVGet al. American Society of Clinical Oncology Policy statement: the role of the oncologist in cancer prevention and risk assessment. J. Clin. Oncol.27(6), 986–989 (2009).
   PubMed Web of Science ®Google Scholar
• Tonini G , D’OnofrioL, Dell’AquilaEet al. New molecular insights in tobacco-induced lung cancer. Future Oncol.9(5), 649–655 (2013).
   PubMed Web of Science ®Google Scholar
• Kim CH , LeeYC, HungRJet al. Second hand tobacco smoke exposure and lung adenocarcinoma in situ/minimally invasive adenocarcinoma (AIS/MIA). Cancer Epidemiol. Biomarkers Prev.24(12), 1902–1906 (2015).
   PubMed Web of Science ®Google Scholar
• Freedman ND , AbnetCC, CaporasoNEet al. Impact of changing US cigarette smoking patterns on incident cancer: risks of 20 smoking-related cancers among the women and men of the NIH AARP cohort. Int. J. Epidemiol. doi: 10.1093/ije/dyv175 (2015) ( Epub ahead of print).
   Google Scholar
• Ben-Zaken Cohen S , ParéPD, ManSFet al. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am. J. Respir. Crit. Care Med.176(2), 113–120 (2007).
   PubMedGoogle Scholar
• Lee HW , WangHT, WengMW. Cigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation. Oncotarget6(32), 33226–33236 (2015).
   PubMedGoogle Scholar
• Schuller HM , CekanovaM. NNK induced hamster lung adenocarcinoma over-express beta2 adrenergic and EGFR signaling pathways. Lung Cancer49(1), 35–45 (2005).
   PubMed Web of Science ®Google Scholar
• Schein JR . Cigarette smoking and clinically significant drug interactions. Ann. Pharmacother.29(11), 1139–1148 (1995).
   PubMed Web of Science ®Google Scholar
• Warren G , SinghA. Nicotine and lung cancer. J. Carcinog.12, 1–12 (2013).
   PubMedGoogle Scholar
• Pal A , MellingG, HinsleyEE. Cigarette smoke condensate promotes pro-tumorigenic stromal–epithelial interactions by suppressing miR-145. J. Oral Pathol. Med.42(4), 309–314 (2013).
   PubMed Web of Science ®Google Scholar
• Pavanello S , FedeliU, MastarngeloG. Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. Cancer Genet.205(6), 278–284 (2012).
   PubMed Web of Science ®Google Scholar
• Liu M , PooWK, LinY-L. Pyrazine, 2-ethylpyridine, and 3-ethylpyridine are cigarette smoke components that alter the growth of normal and malignant human lung cells, and play a role in multidrug resistance development. Exp. Med. Pathol.98, 18–26 (2015).
   PubMed Web of Science ®Google Scholar
• Zhang S , ZhouM, JiangG. Expression and DNA methylation status of the Rap2B gene in human bronchial epithelial cells treated by cigarette smoke condensate. Inhal. Toxicol.27(10), 502–509 (2015).
   PubMed Web of Science ®Google Scholar
• Sirvent JJ , AguilarMC, OlonaMet al. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Histol. Histopathol.19(3), 759–770 (2004).
   PubMed Web of Science ®Google Scholar
• Schaal C , ChellapanS. Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol. Cancer Res.12(1), 14–23 (2014).
   PubMed Web of Science ®Google Scholar
• Ogu CC , MaxaJL. Drug interaction due to cytochrome P450. Proceedings (Bayl Univ. Med. Cent.)13(4), 421–423 (2000).
   PubMedGoogle Scholar
• Abu-Bakar A , HakkolaJ, JuvonenRet al. Function and regulation of the CYP2A5/CYP2A6 genes in response to toxic insults in the liver. Curr. Drug Metabol.14, 137–150 (2013).
   PubMed Web of Science ®Google Scholar
• Abel J , Haarmann-StemmannT. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem.391, 1235–1248 (2010).
   PubMed Web of Science ®Google Scholar
• Arpiainen S , Raffalli-MathieuF, LangMAet al. Regulation of the CYP2A5 gene involves an aryl hydrocarbon-dependent pathway. Mol. Pharmacol.67(4), 1325–1333 (2005).
   PubMed Web of Science ®Google Scholar
• Di YM , ChowVD, YangLPet al. Structure, function, regulation and polymorphism of human cytochrome P450 2A6. Curr. Drug Metab.10, 754–780 (2009).
   PubMed Web of Science ®Google Scholar
• Fujita K . Cytochrome P450 and anticancer drugs. Curr. Drug Metab.7, 23–37 (2006).
   PubMed Web of Science ®Google Scholar
• Schoffer S , YoonS, ZadezenskyI. A review of smoking cessation: potentially risk effects on prescribed medications. J. Clin. Nurs.18, 1533–1540 (2009).
   PubMed Web of Science ®Google Scholar
• Zevin S , BenowitzNL. Drug interactions with tobacco smoking. And upadate. Clin. Pharmacokinet.36(6), 425–438 (1999).
   PubMed Web of Science ®Google Scholar
• Petsalo A , TurpeinenM, PelkonenOet al. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 μm particle size column. J. Chromatog.1215, 107–115 (2008).
   PubMed Web of Science ®Google Scholar
• Tantcheva-Poor I , ZaiglesM, RietbrockSet al. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test. Pharmacogenetics9, 131–144 (1999).
   PubMedGoogle Scholar
• SRNT Subcommittee on Biochemical Verification . Biochemical verification of tobacco use and cessation. Nicotine Tob. Res.4(2), 149–59 (2002).
   PubMedGoogle Scholar
• Hecht SS . Progress and challenges in selected areas of tobacco carcinogenesis. Chem. Res. Toxicol.21, 160–171 (2008).
   PubMed Web of Science ®Google Scholar
• Ring H , ValdesA, NishitaDet al. Gene-gene interactions between CYP 2B6 and CYP 2A6 in nicotine metabolism. Pharmacogenet. Genomics17, 1007–1015 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson DR , KmatakiT, WaxmanDJet al. The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol.12(1), 1–51 (1993).
   PubMed Web of Science ®Google Scholar
• Haeschen C , JangJJ, WeisMet al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat. Med.7(7), 833–839 (2001).
   PubMed Web of Science ®Google Scholar
• D’Souza MS , MarkouA. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict. Sci. Clin. Pract.6(1), 4–16 (2008).
   Google Scholar
• Cattaneo MG , CodignolaA, VicentiniLMet al. Nicotine stimulates a serotonergic autocrine loop in human small-cell lung carcinoma. Cancer Res.53(22), 5566–5568 (1993).
   PubMed Web of Science ®Google Scholar
• Garces YI , YangP, ParkinsonJet al. The relationship between cigarette smoking and quality of life after lung cancer diagnosis. Chest126(6), 1733–1741 (2004).
   PubMed Web of Science ®Google Scholar
• Balduyck B , SardariN, CogenAet al. The effect of smoking cessation on quality of life after lung cancer surgery. Eur. J. Cardiothorac. Surg.40(6), 1432–1437 (2011).
   PubMed Web of Science ®Google Scholar
• Clarck GM , ZborowskiDM, SantabarbaraPet al. Smoking history and epidermal growth factor receptor expression as predictors of survival benefit from erlotinib for patients with non small cell lung cancer in the national cancer institute of Canada clinical trials group study BR. Clin. Lung Cancer7(6), 389–394 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson JR , CohenM, SridharaRet al. Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen. Clin. Cancer Res.11(18), 6414–6421 (2005).
   PubMed Web of Science ®Google Scholar
• Chen J , JiangR, GarcesYIet al. Prognostic factors for limited stage SCLC: a study of 284 patients. Lung Cancer67(2), 221–226 (2010).
   PubMed Web of Science ®Google Scholar
• Zhou W , HeistRS, LiuGet al. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients. Lung Cancer53(3), 375–380 (2006).
   PubMed Web of Science ®Google Scholar
• Di Ciano P , GurandaM, LagzdinsD. Varenicline-induced elevation of dopamine in smokers: a preliminary [(11)C]-(+)-PHNO PET study. Neuropsychopharmacology41(6), 1513–1520 (2016).
   PubMed Web of Science ®Google Scholar
• Ortells MO , AriasHR. Neuronal networks of nicotine addiction. Int. J. Biochem. Cell Biol.42(12), 1931–1935 (2010).
   PubMed Web of Science ®Google Scholar
• Duarte RL , LuizRR, PaschoalME. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients. Lung Cancer61, 244–254 (2008).
   PubMed Web of Science ®Google Scholar
• Han S , ChoiS, ChunYJet al. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol. Pharm. Bull.35(3), 394–399 (2012).
   PubMed Web of Science ®Google Scholar
• Tan X , GuoS, SunHet al. Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in chinese male population. Pharmacogenet. Genomics19, 345–352 (2009).
   PubMed Web of Science ®Google Scholar
• Ahuia R , WeibelSB, LeoneFT. Lung cancer: the oncologist’s role in smoking cessation. Semin. Oncol.30, 94–103 (2003).
   Web of Science ®Google Scholar
• Videtic GM , StittLW, DarARet al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited stage small cell lung cancer is associated with decreased survival. J. Clin. Oncol.21, 1544–1549 (2003).
   PubMed Web of Science ®Google Scholar
• Johnston-Early A , CohenMH, MinnaJDet al. Smoking abstinence and small cell lung cancer survival. An association. JAMA244, 2175–2179 (1980).
   PubMed Web of Science ®Google Scholar
• Tsao A , LiuD, LeeJJet al. Smoking affects treatment outcome in patients with advanced non small cell lung cancer. Cancer106, 2428–2436 (2006).
   PubMedGoogle Scholar
• Florou NA , GkiozosI, TsagouliSet al. Clinical significance of smoking cessation in subjects with cancer a 30 year review. Respir. Care59(12), 1924–1937 (2014).
   PubMed Web of Science ®Google Scholar
• Schuller HM . Neurotransmission and cancer: implication for prevention and therapy. Anticancer Drugs19(7), 655–671 (2008).
   PubMed Web of Science ®Google Scholar
• Shiraishi K , KhonoT, KunitoHet al. Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese. Carcinogenesis30, 65–70 (2009).
   PubMed Web of Science ®Google Scholar
• Wang YY , LiuY, NiXYet al. Nicotine promotes cell proliferation and induces resistance to cisplatin by α7 nicotinic acetylcholine receptor-mediated activation in Raw 264 and El4 cells. Oncol. Rep.31(3), 1480–1488 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang J , KamdarO, LeW, RosenGD, UpadhyayD. Nicotine induces resistance to chemotherapy by modulating mitochondrial signaling in lung cancer. Am. J. Respir. Cell Mol. Biol.40, 135–146 (2009).
   PubMed Web of Science ®Google Scholar
• De Graan AJ , LoosW, FribergLet al. Influence of smoking on the pharmacokinetics and toxicity profile of the taxane therapy. Clin. Cancer Res.18, 4425–4432 (2012).
   PubMed Web of Science ®Google Scholar
• Banerjee J , Al-WadeiHA, Al-WadejMHet al. Differential modulation of nicotine-induced gemcitabine resistance by GABA receptor agonists in pancreatic acncer dell xenografts and in vitro. BMC Cancer14, 725 (2014).
   PubMed Web of Science ®Google Scholar
• Nishioka T , LuoLY, ShenLet al. Nicotine increases the resistance of lung cancer cells to cisplatin through enhancing Bcl-2 stability. Br. J. Cancer110(7), 1785–1792 (2014).
   PubMed Web of Science ®Google Scholar
• Duarte RL , LuizRRet al. The cigarette burden (measured by the number of pack-years smoked) negatively impacts the response rate to platinum-based chemotherapy in lung cancer patients. Lung Cancer61, 244–254 (2008).
   PubMed Web of Science ®Google Scholar
• Dasgupta P , KinkadeR, JoshiBet al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and surviving. Proc. Natl Acad. Sci. USA103, 6332–6337 (2006).
   PubMed Web of Science ®Google Scholar
• Leszczynska KB , FoskolouIP, AbrahamAGet al. Hypoxia-induced p53 modulates both apoptosis and radiosensitivity via AKT. J. Clin. Invest.125(6), 2385–2398 (2015).
   PubMed Web of Science ®Google Scholar
• Kamat AM , SethiG, AggarwalBB. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells. Mol. Cancer Ther.6(3), 1022–1030 (2007).
   PubMed Web of Science ®Google Scholar
• Berger MR , ZellerW. Interaction of nicotine with anticancer treatment. Klin. Wochenschr.66(11), 127–133 (1988).
   PubMedGoogle Scholar
• Scheffer GL , PijnenbergAC, SmitEFet al. Multidrug resistance related molecules in human and murine lung. J. Clin. Pathol.55, 332–339 (2002).
   PubMed Web of Science ®Google Scholar
• Nayan SN , GuptaMK, SommerDD. Evaluating smoking cessation interventions and cessation rates in cancer patients: a systematic review and meta-analysis. ISRN Oncol.2011, 849023 (2011).
   PubMedGoogle Scholar
• Loriot MA , RebuissouS, OscarsonMet al. Genetic polymorphisms of cytochrome P450 2A6 in a case–control study on lung cancer in a French population. Pharmacogenetics11, 39–44 (2001).
   PubMedGoogle Scholar
• Onica T , NicholsK, LarinMet al. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4α to the proximal promoter. Mol. Pharmacol.73, 451–460 (2008).
   PubMed Web of Science ®Google Scholar
• Toyooka S , MatsuoK, ShigematsuHet al. The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer. Clin. Cancer Res.13(19), 5763–5768 (2007).
   PubMed Web of Science ®Google Scholar
• Ying H , DaYangX, SunZet al. Lifestyle risks exposure and response predictor of gefitinib in patients with non-small cell lung cancer. Med. Oncol.31(220), 1–7 (2014).
   Google Scholar
• Wang S , TakayamaK, TanakaKet al. Nicotine induces resistance to epidermal growth factor receptor tyrosine kinase inhibitor by α1 nicotinic acetylcholine receptor-mediated activation in PC9 cells. J. Thorac. Oncol.8, 719–725 (2013).
   PubMed Web of Science ®Google Scholar
• Hughes AN , O’BrienME, PettyWJet al. Overcoming CYPA1/A2 mediated induction metabolism by escalating erlotinib dose in current smokers. J. Clin. Oncol.27(8), 1220–1226 (2009).
   PubMed Web of Science ®Google Scholar
• Liu M , PooWK, LinY-L. Pyrazine, 2-ethylpyridine, and 3-ethylpyridine are cigarette smoke components that alter the growth of normal and malignant human lung cells, and play a role in multidrug resistance development. Exp. Med. Pathol.98, 18–26 (2015).
   PubMed Web of Science ®Google Scholar
• Paul D , ChanukuppaV, ReddyPJ. Global proteomic profiling identifies etoposide chemoresistance markers in non-small cell lung carcinoma. J. Proteomics138, 95–105 (2016).
   PubMed Web of Science ®Google Scholar
• Baser S , ShannonVR, EapenGAet al. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. Chest130(6), 1784–1790 (2006).
   PubMed Web of Science ®Google Scholar
• Videtic G , TruongP, AshRet al. Does sex influence the impact that smoking treatment interruption and impaired pulmonary function have on outcomes in limited stage small cell lung cancer treatment? Cancer Resp. J. 12(5), 245–250 (2005).
   Google Scholar
• Balansky R , IzzottiA, D’AgostiniFet al. Assay of lapatinib in murine models of cigarette smoke carcinogenesis. Carcinogenesis35(10), 2300–2307 (2014).
   PubMed Web of Science ®Google Scholar